Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00987545|
Recruitment Status : Terminated (Negative pharmacodynamics due to lack of Interleukin-13 signature in biomarker data from Part I of the study.)
First Posted : October 1, 2009
Last Update Posted : May 4, 2012
TKL Research, Inc.
Dermatology Consulting Services, High Point NC
Virginia Clinical Research, Inc.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Terminated|
|Actual Primary Completion Date :||November 2010|
|Actual Study Completion Date :||November 2010|
|Certification/Extension First Submitted :||May 2, 2012|